Avidin

Phase 3Small molecule

Sanofi

Avidin is one of 94 small molecule programs targeting Venous thrombosis. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Venous ThrombosisActive, not recruiting

Pulmonary EmbolismActive, not recruiting

Atrial FibrillationActive, not recruiting

Venous ThrombosisPhase 3

Active, not recruiting

Pulmonary EmbolismPhase 3

Active, not recruiting

Atrial FibrillationPhase 3

Active, not recruiting

Competition

Competitive Landscape

376 competitors in Atrial Fibrillation

#DrugCompanyPhaseTrials

Avidin

Sanofi

Phase 3

1 2

Calquence

AstraZeneca

Preclinical

1 3

Calan

VVal Adams

Preclinical

4 4

Rituxan

Brukinsa

1 6

Versed

CConrado Roberto Hoffmann Filho

Preclinical

1 7

Ondexxya

UUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology

Preclinical

1 8

Romazicon

CConrado Roberto Hoffmann Filho

Preclinical

1 9

Imbruvica

PPharmacyclics LLC.

Preclinical

1 10

Xylocaine

MMEDRx USA, Inc.

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Venous thrombosis1 trial

Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower Limbs

Completed· Sanofi logo

Sanofi·Phase 3·NCT00311090·757 enrolled

Atrial Fibrillation1 trial

Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation

Terminated· Sanofi logo

Sanofi·Phase 3·NCT00580216·3,773 enrolled

Pulmonary Embolism1 trial

Clinical Study Assessing Idrabiotaparinux Sodium Injections Once-weekly in Pulmonary Embolism Therapeutic Approach

Completed· Sanofi logo

Sanofi·Phase 3·NCT00345618·3,202 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for Avidin. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Avidin compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Avidin. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Sanofi company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: Sanofi

Avidin

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Venous thrombosis1 trial

Atrial Fibrillation1 trial

Pulmonary Embolism1 trial

References

Drug Info

Quick Facts

Related News